TIAA CREF Investment Management LLC Boosts Stake in Orthofix International N.V. (NASDAQ:OFIX)

TIAA CREF Investment Management LLC lifted its holdings in Orthofix International N.V. (NASDAQ:OFIX) by 34.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 183,179 shares of the medical device company’s stock after acquiring an additional 47,103 shares during the period. TIAA CREF Investment Management LLC owned approximately 1.02% of Orthofix International N.V. worth $8,514,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Paradice Investment Management LLC bought a new position in shares of Orthofix International N.V. in the 2nd quarter worth about $6,642,000. NorthCoast Asset Management LLC raised its position in shares of Orthofix International N.V. by 26.9% in the 2nd quarter. NorthCoast Asset Management LLC now owns 92,952 shares of the medical device company’s stock worth $4,320,000 after acquiring an additional 19,691 shares in the last quarter. Blair William & Co. IL bought a new position in shares of Orthofix International N.V. in the 2nd quarter worth about $1,301,000. OppenheimerFunds Inc. bought a new position in shares of Orthofix International N.V. in the 1st quarter worth about $305,000. Finally, California Public Employees Retirement System raised its position in shares of Orthofix International N.V. by 4.8% in the 1st quarter. California Public Employees Retirement System now owns 61,400 shares of the medical device company’s stock worth $2,342,000 after acquiring an additional 2,800 shares in the last quarter. 96.17% of the stock is owned by hedge funds and other institutional investors.

Shares of Orthofix International N.V. (NASDAQ OFIX) opened at 48.69 on Wednesday. The company has a 50-day moving average price of $48.79 and a 200-day moving average price of $44.57. The company has a market capitalization of $884.70 million, a price-to-earnings ratio of 114.03 and a beta of 0.20. Orthofix International N.V. has a 12 month low of $32.51 and a 12 month high of $51.09.

Orthofix International N.V. (NASDAQ:OFIX) last announced its quarterly earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The company had revenue of $108.90 million during the quarter, compared to the consensus estimate of $102.94 million. During the same quarter last year, the firm earned $0.41 earnings per share. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. On average, equities analysts anticipate that Orthofix International N.V. will post $1.56 EPS for the current year.

Several research analysts have recently weighed in on the company. Zacks Investment Research lowered Orthofix International N.V. from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 11th. BidaskClub raised Orthofix International N.V. from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $55.00 target price (up from $50.00) on shares of Orthofix International N.V. in a research report on Thursday, August 10th. TheStreet raised Orthofix International N.V. from a “c+” rating to a “b-” rating in a research report on Tuesday, August 8th. Finally, BTIG Research started coverage on Orthofix International N.V. in a research report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 target price for the company. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $52.75.

In other Orthofix International N.V. news, insider Raymond Fujikawa sold 6,364 shares of Orthofix International N.V. stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $47.06, for a total value of $299,489.84. Following the sale, the insider now directly owns 31,084 shares in the company, valued at approximately $1,462,813.04. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Brad Mason sold 2,733 shares of Orthofix International N.V. stock in a transaction on Monday, August 21st. The shares were sold at an average price of $48.10, for a total transaction of $131,457.30. Following the completion of the sale, the chief executive officer now owns 188,053 shares in the company, valued at $9,045,349.30. The disclosure for this sale can be found here. Insiders have sold a total of 23,406 shares of company stock worth $1,138,531 in the last quarter. Corporate insiders own 5.60% of the company’s stock.

WARNING: “TIAA CREF Investment Management LLC Boosts Stake in Orthofix International N.V. (NASDAQ:OFIX)” was originally reported by BBNS and is the property of of BBNS. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://baseballnewssource.com/markets/orthofix-international-n-v-ofix-shares-bought-by-tiaa-cref-investment-management-llc/1701000.html.

Orthofix International N.V. Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with our FREE daily email newsletter.

 


Latest News

Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Red Sox Waste Little Time in Firing John Farrell
Red Sox Waste Little Time in Firing John Farrell
Washington Nationals Sans Strasburg for Game 4 at Wrigley
Washington Nationals Sans Strasburg for Game 4 at Wrigley
Red Sox Beat Houston Sunday to Avoid Elimination
Red Sox Beat Houston Sunday to Avoid Elimination


Leave a Reply

 
© 2006-2017 BBNS.